Presentation
13 March 2024 Laser 'combs through' breath: a novel technology for biomedical diagnostics
Author Affiliations +
Abstract
Human exhaled breath contains more than 1,000 volatile organic molecules (biomarkers), combinations of which reflect metabolic processes in the human body. Spectroscopic detection of these biomarkers may be the basis for early diagnosis of various medical conditions. Our detection method, dual-comb spectroscopy (DCS) through the ultra-wideband, 1–100 THz (3–300 µm), spectral range, which targets the strongest vibrational and rotational molecular absorption resonances, relies on optical rectification of few-optical-cycle laser pulses to create mid-IR/THz frequency combs that are subsequently detected by electro-optical sampling (EOS), where the electric field of mid-IR/THz transients induces a change of polarization state of the near-IR probe pulse in the EO crystal. With this technique, we simultaneously achieved superior spectral resolution (via resolving comb lines), real-time detection, broadband (near octave) instantaneous coverage, and massive parallelism of data acquisition. Theoretically, EOS method is sensitive enough to detect vacuum fluctuations, which opens up wide opportunities for the study of quantum effects in biology.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Konstantin L. Vodopyanov "Laser 'combs through' breath: a novel technology for biomedical diagnostics", Proc. SPIE PC12863, Quantum Effects and Measurement Techniques in Biology and Biophotonics, PC1286302 (13 March 2024); https://doi.org/10.1117/12.3003325
Advertisement
Advertisement
KEYWORDS
Biomedical optics

Diagnostics

Laser applications

Quantum detection

Electric fields

Single photon detectors

Spectroscopy

RELATED CONTENT

A biophotonics course for freshman honors students
Proceedings of SPIE (October 24 2005)
Biomedical applications of terahertz technology
Proceedings of SPIE (March 03 2022)

Back to Top